Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
166.4 USD | +0.92% | -0.95% | -7.98% |
05-02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
05-01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.98% | 9.21B | |
-4.79% | 182B | |
+0.23% | 110B | |
-3.90% | 67.92B | |
+2.35% | 50.96B | |
+9.48% | 44.7B | |
+2.70% | 40.66B | |
+21.89% | 27.6B | |
+3.70% | 26.63B | |
-0.50% | 24.98B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 Revenue $155.7M, vs. Street Est of $156.3M